PROGRAMMED CELL DEATH
- 1 September 1998
- journal article
- review article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 66 (6) , 681-691
- https://doi.org/10.1097/00007890-199809270-00001
Abstract
Programmed cell death (PCD) is currently one of the most intensively studied areas in cell biology. Substantial evidence now exists demonstrating the integral role of PCD in many fundamental immunologic processes; therefore, understanding the mechanisms of PCD may provide advances with broad implications in immunobiology. This Overview provides a definition of PCD, a description of known PCD biochemical pathways, and finally a discussion of the implications of PCD in transplantation.Keywords
This publication has 127 references indexed in Scilit:
- Utilization of an in vitro assay to evaluate chromatin degradation by candidate apoptotic nucleasesCell Death & Differentiation, 1997
- Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κBCurrent Biology, 1996
- Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities.Genes & Development, 1996
- Ways around rejectionNature, 1995
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40FEBS Letters, 1995
- DNA fragmentation into 200–250 and/or 30–50 kilobase pair fragments in rat liver nuclei is stimulated by Mg2+ alone and Ca2+/Mg2+ but not by Ca2+ aloneFEBS Letters, 1994
- Conversion of the substrate specificity of mouse proteinase granzyme BNature Structural & Molecular Biology, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992